Yellowish Blisters in Vulva with Known C. glabrata Infection
Yellowish vesicles on the vulva in a patient with known Candida glabrata infection are NOT a typical manifestation of vulvovaginal candidiasis and should prompt immediate consideration of alternative diagnoses, particularly lymphangioma circumscriptum or other vesiculobullous conditions requiring histopathological confirmation.
Clinical Significance and Differential Diagnosis
The presence of vesicles (blisters) is fundamentally inconsistent with the expected presentation of vulvovaginal candidiasis, including C. glabrata infection. According to IDSA guidelines, typical vulvovaginal candidiasis presents with:
- Vulvar edema and erythema
- Excoriation and fissures
- White, thick, curdlike vaginal discharge
- Notably absent: vesicular or blister-like lesions 1
Key Diagnostic Considerations
Primary concern: The vesicular presentation suggests a completely different pathologic process. Lymphangioma circumscriptum presents as grouped vesicles on the vulva and can mimic infectious processes. This benign lymphatic malformation requires histopathological diagnosis to distinguish from genital warts, molluscum contagiosum, or herpes simplex virus 2.
Critical pitfall: Do not assume all vulvar lesions in a patient with known candidiasis are fungal in origin. The CDC guidelines emphasize that vulvovaginal symptoms are nonspecific and clinical diagnosis has poor sensitivity (57.5%) and specificity (89.4%) 3.
Recommended Diagnostic Approach
- Obtain tissue diagnosis: Perform biopsy of vesicular lesions to establish histopathological diagnosis
- Rule out herpes simplex virus: Obtain viral culture or PCR from vesicle fluid
- Confirm active candidiasis: Wet mount with KOH preparation and vaginal pH testing (should be 4.0-4.5 for VVC) 1
- Consider culture: Given C. glabrata's reduced azole susceptibility, culture with susceptibility testing is warranted if candidiasis is confirmed 1
Management of Confirmed C. glabrata Vulvovaginitis
If candidiasis is confirmed alongside the vesicular lesions (representing two separate conditions):
For C. glabrata unresponsive to oral azoles:
- First-line: Intravaginal boric acid 600 mg daily for 14 days 1
- Alternative: Nystatin intravaginal suppositories 100,000 units daily for 14 days 1
- Third option: Topical 17% flucytosine cream ± 3% amphotericin B cream daily for 14 days 1
Important caveat: C. glabrata has intrinsic reduced susceptibility to fluconazole, and the presence of C. glabrata in vaginal cultures may represent colonization rather than active infection 1. Treatment should only be initiated if symptoms are present and other causes excluded.
Clinical Reasoning
The coexistence of vesicular lesions with known C. glabrata colonization/infection represents two distinct clinical entities requiring separate evaluation and management. The vesicles demand tissue diagnosis as they are not explained by candidiasis, while the C. glabrata requires confirmation of active infection before escalating to non-azole therapies given its potential for mere colonization.